Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It is intended to serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. This particular issue on Gastrointestinal Malignancies will also appeal to gastroenterologists, internists, advanced practice nurses, nurses, and scientists involved in the treatment and improvement of outcomes for patients with GI malignancies.